High regression rate of coronary aneurysms developed in patients with immune Globulin-Resistant Kawasaki disease treated with steroid pulse therapy

Tohoku Journal of Experimental Medicine

Volumn 220, Issue 4, 2010, Pages 285-290

  Adachi, Shinya ^a,b,c   Sakaguchi, Heima ^b   Kuwahara, Takashi ^b   Uchida, Yasushi ^c   Fukao, Toshiyuki ^a   Kondo, Naomi ^a  

^a GIFU UNIVERSITY   (Japan)

^b GIFU PREFECTURAL GIFU HOSPITAL   (Japan)

^c NAGARA MEDICAL CENTER   (Japan)

Author keywords

Aneurysm; Immune globulin; Kawasaki disease; Regression; Steroid pulse therapy

Indexed keywords

ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID PLUS DIPYRIDAMOLE; IMMUNOGLOBULIN; METHYLPREDNISOLONE;

ACUTE DISEASE; ARTERY DIAMETER; ARTERY LESION; ARTICLE; CHILD; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CORONARY ARTERY ANEURYSM; DISEASE CLASSIFICATION; DOSE RESPONSE; DRUG MEGADOSE; DRUG PULSE THERAPY; FEMALE; HUMAN; INFANT; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; OUTCOME ASSESSMENT; PATIENT REFERRAL; PRESCHOOL CHILD; REMISSION; SCHOOL CHILD; SINGLE DRUG DOSE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CORONARY ANEURYSM; CORONARY VESSELS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; MIDDLE AGED; MUCOCUTANEOUS LYMPH NODE SYNDROME; STEROIDS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77951230558     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.220.285     Document Type: Article

References (17)

1. Akagi, T., Rose, V., Benson, L.N., Newman, A. & Freedom, R.M. (1992) Outcome of coronary artery aneurysms after Kawasaki disease. J. Pediatr., 121, 689-694.
2. Hashino, K., Ishii, M., Iemura, M., Akagi, T. & Kato, H. (2001) Re-treatment for immune globulin-resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy. Pediatr. Int., 43, 211-217.
3. Iemura, M., Ishii, M., Sugimura, T., Akagi, T. & Kato, H. (2000) Long term consequences of regressed coronary aneurysms after Kawasaki disease: vascular wall morphology and function. Heart, 83, 307-311.
4. Inoue, Y., Okada, Y., Shinohara, M., Kobayashi, T., Kobayashi, T., Tomomasa, T., Takeuchi, K. & Morikawa, A. (2006) A multicenter prospective randomized trial of corticosteroids in primary therapy for Kawasaki disease: clinical course and coronary artery outcome. J. Pediatr., 149, 336-341.
5. Kamiya, T. (1983) Report of Research Committee of Kawasaki Disease: The Evaluation of Coronary Artery Lesions by Echocardiography and Coronary Angiography. The Health and Welfare Press, Tokyo, Japan, pp. 1-10.
6. Kato, H., Sugimura, T., Akagi, T., Sato, N., Hashino, K., Maeno, Y., Kazue, T., Eto, G. & Yamakawa, R. (1996) Long-term consequences of Kawasaki disease. A 10to 21-year follow-up study of 594 patients. Circulation, 94, 1379-1385.
7. Kawasaki, T., Kosaki, F., Okawa, S., Shigematsu, I. & Yanagawa, H. (1974) A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics, 54, 271-276.
8. Kijima, Y., Kamiya, T., Suzuki, A., Hirose, O. & Manabe, H. (1982) A trial procedure to prevent aneurysm formation of the coronary arteries by steroid pulse therapy in Kawasaki disease. Jpn. Circ. J., 46, 1239-1242.
9. Newburger, J.W., Sleeper, L.A., McCrindle, B.W., Minich, L.L., Gersony, W., Vetter, V.L., Atz, A.M., Li, J.S., Takahashi, M., Baker, A.L., Colan, S.D., Mitchell, P.D., Klein, G.L. & Sundel, R.P. (2007) Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease. N. Engl. J. Med., 356, 663-675.
10. Newburger, J.W., Takahashi, M., Burns, J.C., Beiser, A.S., Chung, K.J., Duffy, C.E., Glode, M.P., Mason, W.H., Reddy, V., Sanders, S.P., Shulman, S.T., Wiggins, J.W., Hicks, R.V., Fulton, D.R., Lewis, A.B., Leung, D.Y., Colton, T., Rosen, F.S. & Melish, M.E. (1986) The treatment of Kawasaki syndrome with intravenous gamma globulin. N. Engl. J. Med., 315, 341-347.
11. Onouchi, Z., Hamaoka, K., Sakata, K., Ozawa, S., Shiraishi, I., Itoi, T. & Kiyosawa, N. (2005) Long-term changes in coronary artery aneurysms in patients with Kawasaki disease: comparison of therapeutic regimens. Circ. J., 69, 265-272.
12. Shinohara, M., Sone, K., Tomomasa, T. & Morikawa, A. (1999) Corticosteroids in the treatment of the acute phase of Kawasaki disease. J. Pediatr., 135, 465-469.
13. Sundel, R.P., Burns, J.C., Baker, A., Baker, A.S. & Newburger, J.W. (1993) Gamma globulin re-treatment in Kawasaki disease. J. Pediatr., 123, 657-659.
14. Suzuki, A., Kamiya, T., Arakaki, Y., Kinoshita, Y. & Kimura, K. (1994) Fate of coronary arterial aneurysms in Kawasaki disease. Am. J. Cardiol., 74, 822-824.
15. Wallace, C.A., French, J.W., Kahn, S.J. & Sherry, D.D. (2000) Initial intravenous gammaglobulin treatment failure in Kawasaki disease. Pediatrics, 105, E78.
16. Wooditch, A.C. & Aronoff, S.C. (2005) Effect of initial corticosteroid therapy on coronary artery aneurysm formation in Kawasaki disease: a meta-analysis of 862 children. Pediatrics, 116, 989-995.
17. Wright, D.A., Newburger, J.W., Baker, A. & Sundel, R.P. (1996) Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids. J. Pediatr., 128, 146-149.